Michael Stamatis

Michael Stamatis, Pharm.D., is a Senior Program Director in Product Development Regulatory Affairs at Genentech, where they focus on immuno-oncology early and late-stage development programs. They earned a Bachelor of Science in Pharmaceutical Sciences and a Doctor of Pharmacy from the University of Connecticut, both with honors. Michael has previously held roles at Boehringer Ingelheim and Bristol-Myers Squibb, contributing to regulatory affairs and medical information initiatives. As a post-doctoral fellow at Genentech, they provided regulatory strategy support for various therapeutic areas and played a pivotal role in multiple FDA interactions and submissions.